Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Blood (2018) 132 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2018-99-110568

Published: 2018

Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Blood (2017) 130 (Supplement 1): 317.

https://doi.org/10.1182/blood.V130.Suppl_1.317.317

Published: 2017

Journal Articles

Clinical Signs and Symptoms In Non-Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria From a Korean Prospective PNH Registry

Jong Wook Lee, MD, PhD, Jun Ho Jang, MD, PhD, Jin Seok Kim, MD, Je-Hwan Lee, Deog-Yeon Jo, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Jooseop Chung, MD, PhD, Jeong-A Kim, MD, PhD, Jae Hoon Lee, Chul-Won Choi, MD, PhD, Yong Park, MD, PhD, Jun Sung Park, MD, PhD

Blood (2013) 122 (21): 3720.

https://doi.org/10.1182/blood.V122.21.3720.3720

Published: 2013

Journal Articles

Risk of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria Presenting with Both Clinical Symptoms and Elevated Hemolysis

Jong-Wook Lee, MD, PhD, Jun Ho Jang, MD, PhD, Jin Seok Kim, Sung-Soo Yoon, MD, PhD, Je Hwan Lee, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Jooseop Chung, MD, PhD, Sang Kyun Sohn, MD, PhD

Blood (2012) 120 (21): 1273.

https://doi.org/10.1182/blood.V120.21.1273.1273

Published: 2012

Journal Articles

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

Ho Sup Lee, MD, Lee Chun Park, MD, Eun Mi Lee, Byeong Jin Ye, MD, Joon Ho Moon, M.D., Won Sik Lee, Ho-Jin Shin, Jooseop Chung, MD, PhD, Yang Soo Kim

Blood (2012) 120 (21): 4499.

https://doi.org/10.1182/blood.V120.21.4499.4499

Published: 2012

Journal Articles

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Blood (2011) 118 (21): 3424.

https://doi.org/10.1182/blood.V118.21.3424.3424

Published: 2011

Journal Articles

Impact of Severe Pain on Outcomes in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Jong Wook Lee, MD, PhD, Jun Ho Jang, MD, PhD, Jin Seok Kim, Sung-Soo Yoon, MD, PhD, Je-Hwan Lee, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Jooseop Chung, MD, PhD, Sang Kyun Sohn, MD, PhD

Blood (2011) 118 (21): 5273.

https://doi.org/10.1182/blood.V118.21.5273.5273

Published: 2011

Journal Articles

Uncontrolled Complement Activation and the Resulting Chronic Hemolysis As Measured by LDH Serum Level At Diagnosis As Predictor of Thrombotic Complications and Mortality in a Large Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),

Jong Wook Lee, MD, PhD, Jun Ho Jang, MD, PhD, Jin Seok Kim, Sung-Soo Yoon, MD, PhD, Je-Hwan Lee, MD, PhD, Yeo-Kyeoung Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Jooseop Chung, MD, PhD, Sang Kyun Sohn

Blood (2011) 118 (21): 3166.

https://doi.org/10.1182/blood.V118.21.3166.3166

Published: 2011

Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Blood (2010) 116 (21): 2272.

https://doi.org/10.1182/blood.V116.21.2272.2272

Published: 2010

Journal Articles

Splenic Volume Can Be a Novel Predictive Parameter for the Prognosis of Chronic Lymphocytic Leukemia?

Moo-Kon Song, MD, Jooseop Chung, MD, PhD, Ho-Jin Shin, Young Mi Seol, Young Jin Choi, Ho Sup Lee, Sung Hyun Kim, MD, PhD, Goon Jae Cho

Blood (2010) 116 (21): 4623.

https://doi.org/10.1182/blood.V116.21.4623.4623

Published: 2010

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Yoo-Hong Min, Hyeoung Joon Kim, MD, PhD, Kyoo-Hyung Lee, M.D., PhD., Jae Hoon Lee, MD, PhD, Hee-Sook Park, Jin Seok Kim, Hyeok Shim, MD, Chu-Myung Seung, Chul Soo Kim, Jooseop Chung, MD, PhD, Myung Soo Hyun, Deog-Yeon Jo, MD, PhD, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, MD, PhD, Byung Soo Kim, Young-Don Joo, Chi-Young Park

Blood (2010) 116 (21): 1125.

https://doi.org/10.1182/blood.V116.21.1125.1125

Published: 2010

Journal Articles

Association Between Elevated Hemolysis at Diagnosis and Early Mortality and Risk of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients with Cytopenia

Jin Seok Kim, MD, PhD, Jong Wook Lee, MD, PhD, Sung-Soo Yoon, MD, PhD, Je-Hwan Lee, MD, PhD, Deog-Yeon Jo, MD, PhD, Jun-Ho Jang, MD, PhD, Yeo-Kyung Kim, MD, PhD, Jooseop Chung, MD, PhD, Sang Kyun Sohn, MD, PhD

Blood (2010) 116 (21): 4241.

https://doi.org/10.1182/blood.V116.21.4241.4241

Published: 2010

NARROW

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Clinical Signs and Symptoms In Non-Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria From a Korean Prospective PNH Registry

Risk of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria Presenting with Both Clinical Symptoms and Elevated Hemolysis

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

Hematologic Improvement with Iron Chelation using therapy Deferasirox in Patients with Aplastic Anemia: A Subgroup Analysis of KAMS0112 Prospective Study,

Impact of Severe Pain on Outcomes in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Uncontrolled Complement Activation and the Resulting Chronic Hemolysis As Measured by LDH Serum Level At Diagnosis As Predictor of Thrombotic Complications and Mortality in a Large Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH),

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Splenic Volume Can Be a Novel Predictive Parameter for the Prognosis of Chronic Lymphocytic Leukemia?

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R 2 mri.

Association Between Elevated Hemolysis at Diagnosis and Early Mortality and Risk of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients with Cytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only